SeaSpine to Pursue Aggressive Launch Cadence Despite COVID-19

SeaSpine reported 1Q20 orthopedic revenue of USD $36.1 million, -0.1% vs. 1Q19. The company had significant momentum in 2H19 (+13%) that, according to leadership, carried over into the early portions of the first quarter. COVID-19 procedure deferrals caused an 18% decline in March U.S. spinal implant volumes. These procedure declines were...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us